Intellia Therapeutics (NTLA) — Entry Risk Score

Stock · re-scored every trading day · data as of 2026-11-12

84
on a 30–98 scale
BUY
$10.55last close
+3score vs prior day
71–86range since 10-12
-16.1%price since 10-12

The entry score measures one thing: how far Intellia Therapeutics's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.

On 2026-11-12, Intellia Therapeutics's price sits 1.41 ATR below its 20-day average ($11.75); it trades below its 200-day average ($12.98); its 14-day RSI is 40; it has moved -7.62% over 20 sessions; our regime filter classifies it as no confirmed trend.

Falling-knife flag: this Buy Zone score comes on top of a -15.19% decline over roughly 60 sessions. In our own data that pattern has swung harder than other Buy Zone names in both directions. See the audit.

Is Intellia Therapeutics (NTLA) a buy right now?

Intellia Therapeutics scores 84/98 (Buy) as of 2026-11-12; it is 40.9% below its 52-week high of $17.84; it is below its 200-day average; it moved -7.05% over the last 5 sessions. A high score means our model rates today's price as a favorable, defined-risk entry, based on where it sits versus its 20-day average after adjusting for trend and volatility. It is not a prediction that the price will rise. It also carries a falling-knife flag (down 15.19% over ~60 sessions). Not investment advice.

Score history

80 60

Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.

DateScoreΔClose
2026-11-1284+3$10.55
2026-11-0681-3$11.35
2026-11-0584+10$11.10
2026-11-0474-4$12.31
2026-11-0378-4$11.86
2026-11-0282+9$11.66
2026-10-2973+2$13.23
2026-10-2871-3$13.32
2026-10-2774-9$12.28
2026-10-2683-1$11.26
2026-10-2384-2$11.21
2026-10-2286+4$11.16

Related stocks

See today's full rankings + entry plan for NTLA →

Get the Sunday Brief

One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.